Test Price
2,800 AED✅ Home Collection Available
TMPO Gene Dilated Cardiomyopathy Type 1T (Genetic Test) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين TMPO لاعتلال عضلة القلب التوسعي من النوع 1T في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Clinical Assurance
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for expert result interpretation and family risk counselling.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731; most major UAE insurers accepted.
ملخص تنفيذي: يوفر هذا الاختبار الجيني الدقيق تحليل تسلسل الجين TMPO للكشف عن الطفرات المسببة لاعتلال عضلة القلب التوسعي الوراثي من النوع 1T، مع ضمان الامتثال الكامل لتشريعات دولة الإمارات لعام 2026 ومعايير الجودة العالمية.
UAE Regulatory Compliance: This service fully complies with UAE Federal Decree-Law No. 41 of 2024 (Article 87 – Genetic Testing), CDS Law 2026 (Minors), and UAE PDPL (Genetic Data Privacy). Testing is performed under DHA/MOHAP‑registered laboratory license 9834453.
Test Overview
The TMPO gene test uses Next-Generation Sequencing to detect mutations in the TMPO (thymopoietin) gene, which cause familial dilated cardiomyopathy type 1T – a condition that can lead to heart failure, arrhythmias, and sudden cardiac death. Early identification guides clinical surveillance, family risk assessment, and personalized management under the supervision of a cardiologist and genetic counsellor.
يقوم اختبار الجين TMPO بتحليل الطفرات الوراثية في جين TMPO المرتبطة باعتلال عضلة القلب التوسعي العائلي، مما يساعد في التشخيص المبكر وتقييم المخاطر العائلية ووضع خطة متابعة شخصية.
| Feature | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | Analytical sensitivity >99.9% for single‑nucleotide variants and small indels; ACMG‑guided classification | ~95% sensitivity for targeted regions; limited variant interpretation |
| Method | Next‑Generation Sequencing (Illumina platform) with full coding exon and splice‑site coverage | Sanger (capillary) sequencing of selected exons only |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocol
“Understanding your genetic risk for cardiomyopathy can be life‑saving for you and your family. However, this test is one piece of the puzzle; clinical correlation with cardiac imaging, electrocardiograms, and a thorough family history is essential. Never stop or adjust your heart medications without consulting your cardiologist.”
— Dr. PRABHAKAR REDDY, DHA Licensed Consultant Cardiologist (License No: 61713011)
‼ DO NOT discontinue any prescribed medication without explicit advice from your treating physician. This genetic test is a risk assessment tool, not a replacement for ongoing clinical care.
Patient Safety – Exclusion Criteria & Emergency Red Flags
- This test is not for acute cardiac emergencies or to rule out an ongoing heart failure episode.
- It should not be used as the sole diagnostic criterion for dilated cardiomyopathy; imaging and clinical evaluation are mandatory.
- Not validated for prenatal diagnosis unless specifically approved by a clinical geneticist.
- If you experience severe chest pain, new‑onset severe shortness of breath, fainting, or irregular palpitations, go to the nearest Emergency Department immediately – do not wait for test results.
Frequently Asked Questions & Clinical Guidance
What is the TMPO gene dilated cardiomyopathy type 1T test?
The TMPO gene test is a next‑generation sequencing analysis that identifies pathogenic mutations in the TMPO gene linked to inherited dilated cardiomyopathy type 1T, providing critical data for early diagnosis and family risk stratification.
اختبار جين TMPO هو تحليل تسلسلي من الجيل التالي يكشف الطفرات الممرضة في جين TMPO المرتبطة باعتلال عضلة القلب التوسعي الوراثي نوع 1T. يُستخدم هذا الاختبار لتأكيد التشخيص لدى المرضى الذين تظهر عليهم أعراض أو لديهم تاريخ عائلي، ولتوجيه فحص الأقارب المعرضين للخطر.
How is the test performed and what preparation is needed?
The test requires a standard blood draw, extracted DNA, or a single drop of blood on an FTA card, with no fasting or special preparation; a mandatory genetic counselling session to document family pedigree is performed beforehand.
يتم إجراء الاختبار باستخدام عينة دم عادية أو حمض نووي مستخلص أو نقطة دم على بطاقة FTA، دون الحاجة للصيام. وتسبقه جلسة استشارة وراثية إلزامية لرسم شجرة العائلة وتقييم التاريخ المرضي للعائلة.
What do the results mean and what are the next steps?
A positive result indicates a known pathogenic TMPO mutation that increases lifetime risk for dilated cardiomyopathy and often necessitates regular cardiac surveillance, while a negative result reduces but does not eliminate genetic risk due to possible novel variants.
النتيجة الإيجابية تشير إلى طفرة ممرضة في جين TMPO تزيد خطر الإصابة باعتلال عضلة القلب التوسعي، وتتطلب متابعة قلبية دورية. أما النتيجة السلبية فتقلل الاحتمال الوراثي ولكنها لا تستبعده تمامًا، وقد يُوصى بإجراء فحوصات إضافية حسب توجيهات طبيب القلب.
Primary Specialists Involved: Consultant Cardiologist – diagnostic interpretation & management; Medical & PhD Researcher – variant classification & bioinformatics; Certified Genetic Counsellor – pedigree analysis & pre‑/post‑ counselling.
ICD‑10‑CM 2026 Codes: I42.0 (Dilated cardiomyopathy), Z82.49 (Family history of cardiovascular diseases), Z15.89 (Genetic susceptibility to other disease).
LOINC Code: 82186‑6 – Dilated cardiomyopathy gene panel by Sequencing. View on LOINC.org.
Methodology: Next‑Generation Sequencing (NGS) with full coding region and splice‑site analysis, interpreted per ACMG 2026 guidelines.
Sample & Logistics: Blood (EDTA), Extracted DNA, or One‑drop blood on FTA card. ISO‑certified cold‑chain home collection available daily 8 AM – 11 PM. Turnaround: 3 to 4 weeks.
Contact for Insurance & Scheduling: WhatsApp +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians